Logon or register as member
Preventing stroke in AF: New data on role of antithrombotic therapy
All forms of atrial fibrillation (AF), whether permanent, persistent, or paroxysmal, are associated with an increased risk of stroke and antithrombotic therapy is recommended for almost all AF patients.
Current guidelines are likely to evolve in response to studies that have appeared in the past year. This Data Alert reviews these studies as well as ongoing studies that also may influence clinical practice.
References are listed at the end of the Data Alert.
High incidence of asymptomatic AF
Download DA%20antithrombotic%20therapy.ppt (6 slides - 0.1MB)
Related at vwbg.org
Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial
View/Download individual slides (13 Slides)
Results from CRUSADE: Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines
CRUSADE investigated the association between dosing levels of antithrombotic agents and bleeding, in-hospital mortality, and length of stay in patients with NSTE ACS.
Expanding opportunities for secondary prevention of stroke
Between 1979 and 2001, the number of patients discharged from the hospital with a primary diagnosis of stroke increased by 25%.
© 2017 - VBWG - University of Florida - All rights reserved